Heamgen Research Private Limited
About Heamgen Research Private Limited
Data last updated:
Heamgen Research Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the scientific research segment of the research and development sector. It was incorporated on 13 August 1996.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL1996PTC081155.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.12 Lakh. It was led by directors Siddharth Bhavsar and Rajnikant Birdichand Jain.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at H No – 120 Iind Floor Pocket B – 4 Sector 8 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2017, the company reported a revenue of ₹13.2 Lakh. For the same year it recorded a net loss of ₹13.57 Lakh (net margin -102.8%) and EBITDA of -₹13.57 Lakh (EBITDA margin -102.8%).
Company details
CIN history
Heamgen Research has one previous CIN (Corporate Identification Number): U51909DL1996PTC081155. The current CIN is U73100DL1996PTC081155, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100DL1996PTC081155 | Current |
| U51909DL1996PTC081155 | Previous |
Contact details
Heamgen Research Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No – 120 Iind Floor Pocket B – 4 Sector 8 Rohini, Delhi, India – 110085
- IndustryResearch & Development, Science Research
To see the full contact details of Heamgen Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Heamgen Research Private Limited
FY 2017 filings availableHeamgen Research Private Limited reported revenue of ₹13.2 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹13.2 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹13.57 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹13.57 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -102.8% | ||
| Net Profit Margin | -102.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Heamgen Research Private Limited, buy the company report.
Board of directors of Heamgen Research Private Limited
Heamgen Research has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Bhavsar Also directs: Graphene Research Labs Private Limited, Giostar Research Private Limited, Giostar Healthcare Private Limited and 1 more | Additional Director | 18 Oct 2014 | 12 Years 0 Months | As last reported |
| Rajnikant Birdichand Jain Also directs: Aditi Advanced Materials Private Limited | Additional Director | 23 Mar 2015 | 11 Years 7 Months | As last reported |
Auditor
Heamgen Research Private Limited is audited by K K BARANWAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K K BARANWAL & ASSOCIATES | FY 2017 | 024207N |
Shareholding
The shareholding of Heamgen Research Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Heamgen Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Heamgen Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Heamgen Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Heamgen Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Heamgen Research Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Gourav Soni ceased to be Additional Director on 01 Jul 2015.
Frequently asked questions
Heamgen Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Heamgen Research was a private limited company based in Delhi, India. The company worked in science research, within the research and development industry. It was incorporated on 13 August 1996 and is registered under CIN U73100DL1996PTC081155. The company has been struck off by the Registrar of Companies and is no longer operational.
Heamgen Research had 2 directors:
- Siddharth Bhavsar - Additional Director
- Rajnikant Birdichand Jain - Additional Director
The CIN (Corporate Identification Number) of Heamgen Research is U73100DL1996PTC081155. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Heamgen Research is at H No – 120 Iind Floor Pocket B – 4 Sector 8 Rohini, Delhi, India – 110085.
Heamgen Research was incorporated on 13 August 1996. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Heamgen Research on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
Heamgen Research operated in the research and development industry, in the science research segment. It worked in this industry before it was struck off.
Gourav Soni ceased to be Additional Director on 01 Jul 2015. Rajnikant Birdichand Jain was appointed as Additional Director on 23 Mar 2015. Santosh Killa ceased to be Director on 03 Mar 2015. Heamgen Research has 5 board changes on record in total.
The compliance status of Heamgen Research is active non-compliant as of 22 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
